Neurocrine Biosciences | NBIX - Eps Ganancias Por Acción


Fiscal Calendario Real Consenso Anterior Fecha
FY2026Q1 Mar/2026 1.94 1.15 0.70 May/05
FY2025Q4 Dec/2025 1.88 1.86 1.69 Feb/11
FY2025Q3 Sep/2025 2.17 1.56 1.81 Oct/28
FY2025Q2 Jun/2025 1.65 0.98 1.63 Jul/30
FY2025Q1 Mar/2025 0.70 0.86 1.20 May/05




Eps Cambio Fecha
AbbVie USD 2.65 0.06 2026-03
Acadia Pharmaceuticals USD 0.02 1.58 2026-03
Agios Pharmaceuticals USD -1.69 0.17 2026-03
ALKERMES USD -0.4 0.69 2026-03
Alnylam Pharmaceuticals USD 1.99 0.74 2026-03
Amgen USD 5.15 0.14 2026-03
Biogen USD 3.57 1.58 2026-03
BioMarin Pharmaceutical USD 0.76 0.3 2026-03
Cytokinetics USD -1.67 0.17 2026-03
Enanta Pharmaceuticals USD -1.05 0.31 2024-12
Exelixis USD 0.87 0.1 2026-03
Gilead Sciences USD 2.03 0.17 2026-03
Halozyme Therapeutics USD 1.6 1.84 2026-03
Incyte USD 1.81 0.01 2026-03
Ionis Pharmaceuticals USD -0.56 0.85 2026-03
Nektar Therapeutics USD -1.35 1.17 2025-12
Neurocrine Biosciences USD 1.94 0.06 2026-03
Pfizer USD 0.75 0.09 2026-03
Prothena USD 0.6 1.06 2026-03
Regeneron Pharmaceuticals USD 9.47 1.97 2026-03
Repligen USD 0.48 0.01 2026-03
Rigel Pharmaceuticals USD 0.7 0.76 2024-09
Sarepta Therapeutics USD 3.16 6.74 2026-03
Teva Pharmaceutical Industries USD 1.57 1.41 2026-03
Ultragenyx Pharmaceutical USD -1.84 0.55 2026-03
Vertex Pharmaceuticals USD 4.47 0.56 2026-03
Xoma USD -1.59 2.43 2024-09